The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs.
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Interleukin-12 (IL-12) plays a key role in promoting T helper 1 (Th1) responses and subsequent cell-mediated immunity. Given the role of cytokines in the pathogenesis of psychiatric disorders, the dysregulation of IL-12 in these illnesses would be expected. We measured the plasma levels of IL-12 in 102 psychiatric patients (43 schizophrenia, 34 major depression and 25 bipolar disorder) and 85 normal controls. In addition, IL-12 levels of the patients were measured after an 8-week treatment to assess whether the levels were affected by medication. The IL-12 levels of the patient group with major depression were significantly higher than that of the control group, whereas no differences were found among the other groups. IL-12 values of the three patient groups decreased significantly after 8 weeks of treatment. These findings support the hypothesis that activation of the inflammatory response system and in particular of Th-1-like cells, is involved in the pathophysiology of major depression and that repeated administration of antidepressive and antipsychotic drugs may suppress IL-12 plasma concentrations in psychiatric patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated pro-inflammatory cytokines had been reported to be associated with greater symptom burden in BD (14, 15), and correlation between severity of affective symptoms and serum levels of IL-6, sIL-2R, sIL-6R, TNF-α and tumor necrosis factor receptor 60 and 80 kDa (sTNFR60/80) was found in several studies (16–21).”
From Are serum levels of inflammatory markers associated with the severity of symptoms of bipolar disorder? (2023) · cites this paper as [19]
In the citing paper
“there was a significant decrease in IL-12 plasma levels after eight weeks of antidepressant pharmacotherapy [118].”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [118]
In the citing paper
“the plasma levels of IL-12 were significantly higher in patients with depression compared to controls”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [118]
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Trinchieri, G. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.001343 · Cited by 2,399
THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses
Gately, M. K., Renzetti, L. M., Magram, J., Stern, A. S., Adorini, L., Gubler, U., & Presky, D. H. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.495 · Cited by 1,231
Evidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003
Major Depression and Activation of The Inflammatory Response System
Maes, M. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_2 · Cited by 617
Depression, stress and immunological activation: The role of cytokines in depressive disorders
Connor, T. J., & Leonard, B. E. (1998) · Life Sciences · doi:10.1016/s0024-3205(97)00990-9 · Cited by 482
Maes, M., Bosmans, E., Calabrese, J., Smith, R., & Meltzer, H. Y. (1995) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)00049-w · Cited by 385
Licinio, J., & Wong, M.-L. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000586 · Cited by 380
Self-citation
Research works printed but not linked: 2
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn) American Psychiatric Press: Washington DC 1994
- First MB, Gibbon M, Spitzer RL, Williams JBW . Structural Clinical Interview for DSM-IV Research Version Biometric Research Department, New York Psychiatric Institute: New York 1998
Cited by
Items 201–227 of 227
Depression and immunity: biological and behavioural mechanisms
Irwin, M. R. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544293.015 · Cited by 2
Szeszko, P. R., Chan, C. C., Ramakrishnan, A., Rizk, M., Baptista, I., Alter, S., Haznedar, M. M., Chu, K.-W., Xie, H., Yehuda, R., et al. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106836 · Cited by 1
Puri, B. K. (2006) · Humana Press eBooks · doi:10.1385/1-59259-952-4:221 · Cited by 1
Miller, B. J., Buckley, P. F., Seabolt, W., Mellor, A. L., & Kirkpatrick, B. W. (2011) · Psiquiatría Biológica · doi:10.1016/j.psiq.2011.10.006 · Cited by 2
The role of the immune system in the pathophysiology of schizophrenia
Kim, Y., & Maes, M. H. J. (2005) · CRC Press eBooks · doi:10.3109/9780203007648-6 · Cited by 1
Self-citationDortaj, A., Moghadasi, A. N., Dehkordi, M. A., & Alipour, A. (2019) · International Journal of Applied Behavioral Sciences · doi:10.22037/ijabs.v6i6.28313 · Cited by 5
Neurochemistry immune systems interaction in depression
Myint, A.-M. (2007) · Research Publications (Maastricht University) · doi:10.26481/dis.20070118am · Cited by 3
Zareie, P. (2017) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17065139 · Cited by 2
Entzündliche Veränderungen als gemeinsame Pathogenese affektiver und schizophrener Erkrankungen
Müller, N., & Schwarz, M. (2010) · Springer eBooks · doi:10.1007/978-3-211-92215-6_5 · Cited by 1
Bipolar Disorder: not only in the Brain - immunological aspects
Knijff, E. M. (2006) · RePub (Erasmus University Rotterdam)
Developmental and psychoneuroimmunological mechanisms in depression
Pujol-Lopez, Y. (2015) · Research Publications (Maastricht University) · doi:10.26481/dis.20151030yp
Estudo da Inflamação no Transtorno Afetivo Bipolar:
dos Santos, M. G., Faria, M. B. G., Borges, K. D. S., Júnior, A. L. T., & Sousa, L. P. (2014) · Revista Neurociências · doi:10.4181/rnc.2014.22.898.10p
Immune dysregulation in bipolar disorder
Teixeira, A. L., Barbosa, I. G., & Bauer, M. E. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107477278.022 · Cited by 1
Irwin, M. R. (2013) · Oxford University Press eBooks · doi:10.1093/med/9780199796816.003.0039
Bernabeu, P. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
The treatment of bipolar disorder in the era of precision psychiatry: Challenges and opportunities
Fernandes, B. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819182-8.00038-7
Shirts, B. H. (2006) · D-Scholarship@Pitt (University of Pittsburgh)
Tapnikar, S. (2021) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.16910950 · Cited by 1
Restrepo, J. E., Zapata, W., Ossa-Giraldo, A. C., & Montoya, G. P. C. (2022) · Informes Psicológicos · doi:10.18566/infpsic.v22n2a04
Vera-Montecinos, A., & Ramos, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083653 · Cited by 1
“In this sense, altered IL-12 levels have been reported in the plasma of SZ subjects [88,89].”
Samuelsson, M. (2012) · DiVA (Linkoping University)
Cognitive decline in Mfn2 KO mice: role of Mfn2 in neuronal plasticity
Riqué Pujol, G. (2025) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Nur, T. A., Munny, F. A., Qusar, M. S., Islam, M. R., & Nahar, Z. (2026) · Developmental Neurobiology · doi:10.1002/dneu.70025
“This study demonstrated increased serum IL-12 levels in GAD patients compared to HCs, consistent with findings from several previous studies concerning neuropsychiatric disorders (Ross et al. 2013 ; Yang et al. 2022 , 2024; Kim et al. 2002 ).”
Shao, M., Zhu, T., Hu, X., Fang, X., Pan, X., Wen, L., Dai, P., Amdanee, N., Zhang, L., Xu, Y., et al. (2026) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253261432764
“88 Therefore, our observation could align with a pharmacological adaptation in which higher drug exposure modulates the inflammatory response.”
Calesella, F. (n.d.) · Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele · Cited by 1
Tukiran, N., Kolb, T., Maggioni, L., Rai, S., Rafath, Z., & Borsini, A. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.107069
Metadata
- Authors
- Kim, Y.-K., Suh, I.-B., Kim, H., Han, C.-S., Lim, C.-S., Choi, S.-H., & Licinio, J.
- Affiliations
- Korea University Ansan Hospital (KR)
- Korea University (KR)
- Yongin Mental Hospital (KR)
- University of California, Los Angeles (US)
- Corresponding author
- Kim, H
- ORCID
- Venue
- Molecular Psychiatry
- Published
- 2002-12-01
- Volume
- 7
- Issue
- 10
- Pages
- 1107-1114
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W1992868687
- Cited by
- 224
- References
- 62
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 4 · 2023: 6 · 2022: 9 · 2021: 7 · 2020: 16 · 2019: 8 · 2018: 5 · 2017: 9 · 2016: 17 · 2015: 14 · 2014: 12 · 2013: 9 · 2012: 19
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- IL-12, schizophrenia, major depressive disorder, bipolar mania, psychotropic drugs, antidepressants, antipsychotic drugs, cytokines, Th1 response, plasma cytokines
- MeSH terms
- Adolescent, Adult, Aged, Bipolar Disorder, Depressive Disorder, Female, Humans, Male, Middle Aged, Psychotropic Drugs, Reference Values, Schizophrenia, Th1 Cells, Interleukin-12
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.